Science Explorer Back to mapMap
Discussion
Researcher · Jouf University · Saudi Arabia

Mohammed Elmowafy

Mohammed Elmowafy publishes mostly in Pharmaceutical Science, Molecular Biology and Dermatology, on topics such as Advanced Drug Delivery Systems, Advancements in Transdermal Drug Delivery and Drug Solubulity and Delivery Systems.

ORCID 0000-0002-2393-8195 OpenAlex
World rank
#273,172
of 7,710,434 ranked researchers
Rank in Saudi Arabia
#1,073
of 25,688
Works
77
Citations
3k
Citations per work
38.6
h-index
29
i10-index 49Top 12% in Pharmaceutical Science
Mohammed Elmowafy

What does Mohammed Elmowafy research?

Mohammed Elmowafy's work is mostly in Pharmacology, Toxicology and Pharmaceutics (32%), Medicine (15%), Biochemistry, Genetics and Molecular Biology (10%).

Life Sciences: 36 works · 46.6% of their workPharmacology, Toxicology and Pharmaceutics: 25 works · 32.0% of their workPharmaceutical Science: 25 works · 32.0% of their workBiochemistry, Genetics and Molecular Biology: 7 works · 9.6% of their workMolecular Biology: 7 works · 9.6% of their workAgricultural and Biological Sciences: 4 works · 5.0% of their workFood Science: 4 works · 5.0% of their workEverything else: 30 works · 38.7% of their workHealth Sciences: 11 works · 14.7% of their workMedicine: 11 works · 14.7% of their workDermatology: 4 works · 5.5% of their workOncology: 4 works · 4.6% of their workPharmacology: 4 works · 4.6% of their workTHEIR WORKMohammed Elmowafy77works
Life Sciences47%Health Sciences15%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Pharmacology, Toxicology and Pharmaceutics2532.0%
    2. Biochemistry, Genetics and Molecular Biology79.6%
    3. Agricultural and Biological Sciences45.0%
  2. Everything else3038.7%
    1. Medicine1114.7%
  1. 1Pharmaceutical Science32% of their works
  2. 2Molecular Biology10% of their works
  3. 3Dermatology6% of their works
  4. 4Food Science5% of their works
  5. 5Oncology5% of their works
  6. 6Pharmacology5% of their works

Research topics

Which keywords describe Mohammed Elmowafy's research?

The keywords of their largest research topics: Drug Delivery, Nanoparticles, Chitosan, Mucosal, Microneedles, Solid Lipid Nanoparticles, Cyclodextrins and Solid Dispersions.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Drug Delivery332 topics
  2. Nanoparticles332 topics
  3. Chitosan281 topic
  4. Mucosal281 topic
  5. Microneedles261 topic
  6. Solid Lipid Nanoparticles261 topic
  7. Cyclodextrins161 topic
  8. Solid Dispersions161 topic
  9. Dry Eye Disease71 topic
  10. Filaggrin71 topic
  11. Ocular Surface71 topic
  12. Skin Microbiome71 topic
  13. Cancer Therapy51 topic
  14. Heterocyclic Compounds51 topic
  15. Lipid Rafts51 topic
  16. Medicinal Chemistry51 topic
  17. Membrane Lipids51 topic
  18. Nanocarriers51 topic

Where does Mohammed Elmowafy work?

Mohammed Elmowafy's main affiliation in the publication record is Jouf University, Saudi Arabia.

How many publications and citations does Mohammed Elmowafy have?

OpenAlex counts 77 works and 2,971 citations for Mohammed Elmowafy, an h-index of 29, ranking #273,172 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mohammed Elmowafy. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.